$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
安圣莎在国内上市了没呢?
2025-10-19 11:44:20
Check Details
安圣莎治疗效果怎么样呢?
2025-10-19 11:44:20
Check Details
易瑞沙需注意什么事项?
2025-10-19 11:44:20
Check Details
安圣莎应怎么使用?
2025-10-19 11:44:20
Check Details
国内怎么购买易瑞沙?
2025-10-19 11:44:20
Check Details
易瑞沙的价格是多少呢?
2025-10-19 11:44:20
Check Details
用易瑞沙可能出现耐药情况吗?
2025-10-19 11:44:20
Check Details
安圣莎国内上市了吗?
2025-10-19 11:44:20
Check Details
易瑞沙的价格
2025-10-19 11:44:20
Check Details
安圣莎(阿来替尼) 说明书
2025-10-19 11:44:20
Check Details
安圣莎(阿来替尼)需注意的事项有什么?
2025-10-19 11:44:20
Check Details
安圣莎治疗肺癌疗效怎样呢?
2025-10-19 11:44:20
Check Details
1
2
...
3364
3365
3366
3367
3368
3369
3370
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
4
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
5
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
6
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
7
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
8
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
9
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
10
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
11
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
12
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management